These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
310 related items for PubMed ID: 16390022
1. The role of 99mTc(V)-DMSA scan as compared to 99mTc-MDP and CT scans in imaging the primary tumor and metastases of osteosarcoma. Zissimopoulos A, Zanglis A, Andreopoulos D, Baziotis N. Hell J Nucl Med; 2005; 8(3):162-4. PubMed ID: 16390022 [Abstract] [Full Text] [Related]
2. Brain metastasis from breast cancer detected by 99mTc (V) DMSA SPET scintigraphy. Sotiropoulou E, Valsamaki P, Tsiouris S, Ptohis N, Papantoniou V. Hell J Nucl Med; 2009; 12(1):71. PubMed ID: 19330192 [No Abstract] [Full Text] [Related]
3. Diagnostic value of 99mTc-methylene diphosphonate and 99mTc-pentavalent DMSA compared with 99mTc-sestamibi for palpable breast lesions. Massardo T, Alonso O, Kabasakal L, Llamas-Olier A, Shankar UR, Zhu H, Delgado L, González P, Mut F, Padhy AK. J Nucl Med; 2002 Jul; 43(7):882-8. PubMed ID: 12097457 [Abstract] [Full Text] [Related]
4. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions. Ergün EL, Kara PO, Gedik GK, Kars A, Türker A, Caner B. Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845 [Abstract] [Full Text] [Related]
5. Evaluation of metastatic bone disease with pentavalent 99Tc(m)-dimercaptosuccinic acid: a comparison with whole-body scanning and 4/24 hour quantitation of vertebral lesions. Sahin M, Basoglu T, Bernay I, Yapici O, Canbaz F, Yalin T. Nucl Med Commun; 2000 Mar; 21(3):251-8. PubMed ID: 10823327 [Abstract] [Full Text] [Related]
6. Comparative radionuclide imaging of metastatic insular carcinoma of the thyroid: value of technetium-99m-(V)DMSA. Yen TC, King KL, Yang AH, Liu RS, Yeh SH. J Nucl Med; 1996 Jan; 37(1):78-80. PubMed ID: 8544007 [Abstract] [Full Text] [Related]
7. Pentavalent [99mTc]DMSA, [131I]MIBG, and [99mTc]MDP--an evaluation of three imaging techniques in patients with medullary carcinoma of the thyroid. Clarke SE, Lazarus CR, Wraight P, Sampson C, Maisey MN. J Nucl Med; 1988 Jan; 29(1):33-8. PubMed ID: 2826723 [Abstract] [Full Text] [Related]
8. Tc-99m(V) DMSA imaging. A new approach to studying metastases from breast carcinoma. Kashyap R, Babbar A, Sahai I, Prakash R, Soni NL, Chauhan UP. Clin Nucl Med; 1992 Feb; 17(2):119-22. PubMed ID: 1314148 [Abstract] [Full Text] [Related]
9. Diagnostic efficacy of technetium-99m pentavalent-dimercapto succinic acid versus gallium-67 citrate, imaging in patients with highly suspected acute bone and joint infections. Koukouraki S, Gaitanis I, Hatjipaulou A, Karkavitsas N. Hell J Nucl Med; 2006 Feb; 9(2):99-102. PubMed ID: 16894413 [Abstract] [Full Text] [Related]
10. 99Tc(m)(V)DMSA scintigraphy in skeletal metastases and superscans arising from various malignancies: diagnosis, treatment monitoring and therapeutic implications. Basu S, Nair N, Awasare S, Tiwari BP, Asopa R, Nair C. Br J Radiol; 2004 Apr; 77(916):347-61. PubMed ID: 15107330 [Abstract] [Full Text] [Related]
11. Comparison of 99mTc(V)-DMSA, 201Tl and 99mTc-MIBI imaging in the follow-up of patients with medullary carcinoma of the thyroid. Ugur O, Kostakğlu L, Güler N, Caner B, Uysal U, Elahi N, Haliloğlu M, Yüksel D, Aras T, Bayhan H, Bekdik C. Eur J Nucl Med; 1996 Oct; 23(10):1367-71. PubMed ID: 8781142 [Abstract] [Full Text] [Related]
12. Analogy between tumor uptake of technetium(V)-99m dimercaptosuccinic acid (DMSA) and technetium-99m-MDP. Wulfrank DA, Schelstraete KH, Small F, Fallais CJ. Clin Nucl Med; 1989 Aug; 14(8):588-93. PubMed ID: 2553315 [Abstract] [Full Text] [Related]
13. 99mTc(V)DMSA quantitatively predicts 188Re(V)DMSA distribution in patients with prostate cancer metastatic to bone. Blower PJ, Kettle AG, O'Doherty MJ, Coakley AJ, Knapp FF. Eur J Nucl Med; 2000 Sep; 27(9):1405-9. PubMed ID: 11007525 [Abstract] [Full Text] [Related]
14. Detection of lung metastases from osteosarcoma by scintigraphy using 99mTc-methylene diphosphonate. Hoefnagel CA, Bruning PF, Cohen P, Marcuse HR, van der Schoot JB. Diagn Imaging; 1981 Sep; 50(5):277-84. PubMed ID: 6457735 [Abstract] [Full Text] [Related]
15. The role of Tc-99m (V) DMSA scintigraphy in the evaluation of superscan on bone scintigraphy. Yüksel D, Ilgan S, Arslan N, Uğur O, Oztürk E, Bayhan H. Clin Nucl Med; 2000 Mar; 25(3):193-6. PubMed ID: 10698416 [Abstract] [Full Text] [Related]
16. Technetium-99m(V)-DMSA and thallium-201 in brain tumor imaging: correlation with histology and malignant grade. Hirano T, Otake H, Kazama K, Wakabayashi K, Zama A, Shibasaki T, Tamura M, Endo K. J Nucl Med; 1997 Nov; 38(11):1741-9. PubMed ID: 9374344 [Abstract] [Full Text] [Related]
17. Tc-99m-(V)-DMSA: the new sensitive and specific radiopharmaceutical for imaging metastases of medullary thyroid carcinomas? Becker W, Börner W, Reiners C. Horm Metab Res Suppl; 1989 Nov; 21():38-42. PubMed ID: 2553574 [Abstract] [Full Text] [Related]
18. Pentavalent 99Tcm-DMSA imaging in patients with bone metastases. Lam AS, Kettle AG, O'Doherty MJ, Coakley AJ, Barrington SF, Blower PJ. Nucl Med Commun; 1997 Oct; 18(10):907-14. PubMed ID: 9392790 [Abstract] [Full Text] [Related]